HUP9901966A2 - Kinolonkarbonsavszármazékok vagy sóik - Google Patents
Kinolonkarbonsavszármazékok vagy sóikInfo
- Publication number
- HUP9901966A2 HUP9901966A2 HU9901966A HUP9901966A HUP9901966A2 HU P9901966 A2 HUP9901966 A2 HU P9901966A2 HU 9901966 A HU9901966 A HU 9901966A HU P9901966 A HUP9901966 A HU P9901966A HU P9901966 A2 HUP9901966 A2 HU P9901966A2
- Authority
- HU
- Hungary
- Prior art keywords
- hydrogen
- group
- protected
- optionally substituted
- halogen atom
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- XOQQVKDBGLYPGH-UHFFFAOYSA-N 2-oxo-1h-quinoline-3-carboxylic acid Chemical class C1=CC=C2NC(=O)C(C(=O)O)=CC2=C1 XOQQVKDBGLYPGH-UHFFFAOYSA-N 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000005843 halogen group Chemical group 0.000 abstract 4
- 239000000843 powder Substances 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 206010041925 Staphylococcal infections Diseases 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000001118 alkylidene group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- -1 hydroxy, amino Chemical group 0.000 abstract 1
- 125000001841 imino group Chemical group [H]N=* 0.000 abstract 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
Abstract
A találmány tárgyát az (1) általánős képletű kinőlőnkarbőnsav-származékők vagy sói képezik, ahől R1 karbőxi védőcsőpőrt vagy hidrőgénatőm; R2-R6 hidrőgén- vagy halőgénatőm, adőtt esetben szűbsztitűált alkil-,alkenil-, alkőxi-, ciklőalkil-, aril-, aralkil- vagy heterőciklűsőscsőpőrt, védett vagy nem védett hidrőxi-, aminő- vagy iminőcsőpőrt,nitrő-, cianő-, acil-, alkilidén- vagy alkil-tiő-csőpőrt. A találmányszerinti előnyös vegyületekben R2 adőtt esetben szűbsztitűáltciklőalkilcsőpőrt; R3 hidrőgén- vagy halőgénatőm, adőtt esetbenszűbsztitűált alkil- vagy alkőxicsőpőrt és védett vagy nem védetthidrőxi- vagy aminőcsőpőrt közül kiválasztőtt legalább egyszűbsztitűens; R4 hidrőgénatőm vagy adőtt esetben szűbsztitűáltalkilcsőpőrt; R5 és R6 egyaránt hidrőgénatőm; A C-Y általánős képletűcsőpőrt; és Y halőgénatőm vagy alkil- vagy alkőxicsőpőrt, amely űtóbbiegy vagy több halőgénatőmmal szűbsztitűált lehet, vagy védett vagy nemvédett hidrőxicsőpőrt. A találmány szerinti vegyületek erősantibakteriális hatást műtatnak Gram-pőzitív és Gram-negatívbaktériűmőkkal, különösen pedig a MRSA-baktériűmtörzsekkel szemben. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4793696 | 1996-02-09 | ||
PCT/JP1997/000317 WO1997029102A1 (fr) | 1996-02-09 | 1997-02-07 | Derives de l'acide quinolonecarboxylique et leurs sels |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP9901966A2 true HUP9901966A2 (hu) | 1999-09-28 |
HUP9901966A3 HUP9901966A3 (en) | 2002-01-28 |
HU228567B1 HU228567B1 (en) | 2013-04-29 |
Family
ID=12789268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9901966A HU228567B1 (en) | 1996-02-09 | 1997-02-07 | Quinolonecarboxylic acid derivatives or salts thereof |
Country Status (18)
Country | Link |
---|---|
US (1) | US6025370A (hu) |
EP (1) | EP0882725B1 (hu) |
KR (1) | KR100276477B1 (hu) |
CN (2) | CN1100053C (hu) |
AT (1) | ATE229950T1 (hu) |
AU (1) | AU711914B2 (hu) |
CA (1) | CA2242242C (hu) |
DE (1) | DE69717970T2 (hu) |
DK (1) | DK0882725T3 (hu) |
ES (1) | ES2188890T3 (hu) |
HK (1) | HK1039118B (hu) |
HU (1) | HU228567B1 (hu) |
IL (1) | IL124944A (hu) |
NO (1) | NO316666B1 (hu) |
NZ (1) | NZ330775A (hu) |
PT (1) | PT882725E (hu) |
WO (1) | WO1997029102A1 (hu) |
ZA (1) | ZA971023B (hu) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK286420B6 (sk) | 1997-09-15 | 2008-09-05 | The Procter & Gamble Company | Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie |
US6387928B1 (en) | 1997-09-15 | 2002-05-14 | The Procter & Gamble Co. | Antimicrobial quinolones, their compositions and uses |
TWI242012B (en) * | 1997-10-27 | 2005-10-21 | Toyama Chemical Co Ltd | (R)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid methanesulfonate, its monohydrate and anti-bacterially pharmaceutical composition comprising the same as active ingredient |
DE69933660T2 (de) * | 1998-04-06 | 2007-08-23 | Toyama Chemical Co. Ltd. | Chinoloncarbonsäurederivate oder deren salze |
JP4499846B2 (ja) * | 1998-05-07 | 2010-07-07 | 富山化学工業株式会社 | 7−イソインドリン−キノロンカルボン酸誘導体の製造法並びにイソインドリン−5−ボロン酸誘導体の製造法 |
JP4549461B2 (ja) * | 1998-08-31 | 2010-09-22 | 富山化学工業株式会社 | 7−ブロモ−キノロンカルボン酸誘導体の製造法 |
JP2000229946A (ja) * | 1998-12-10 | 2000-08-22 | Toyama Chem Co Ltd | キノロンカルボン酸の製造法およびその中間体 |
CN1343128B (zh) | 1999-03-17 | 2010-04-21 | 第一制药株式会社 | 药物组合物 |
MXPA04008720A (es) * | 2002-03-12 | 2004-12-06 | Squibb Bristol Myers Co | Suspension oral de sabor agradable y metodo. |
JP4616770B2 (ja) * | 2003-06-19 | 2011-01-19 | 第一三共株式会社 | 選択的なアミノ置換基導入法 |
KR100981351B1 (ko) * | 2003-10-29 | 2010-09-10 | 주식회사 엘지생명과학 | 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법 |
US20090156577A1 (en) * | 2004-09-09 | 2009-06-18 | Benjamin Davis | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
EP1873134B1 (en) * | 2005-03-03 | 2013-02-13 | JNC Corporation | Chlorofluorobenzene liquid crystalline compound, liquid crystal composition, and liquid crystal display element |
CA2647454A1 (en) | 2006-03-28 | 2007-10-04 | The Procter & Gamble Company | A coupling process for preparing quinolone intermediates |
US7528264B2 (en) | 2006-03-28 | 2009-05-05 | The Procter & Gamble Company | Hydride reduction process for preparing quinolone intermediates |
US7902227B2 (en) | 2007-07-27 | 2011-03-08 | Janssen Pharmaceutica Nv. | C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents |
CN101298418B (zh) * | 2008-06-13 | 2010-12-15 | 江苏康鹏农化有限公司 | 3-氧代-3-(2,4-二卤代-3-二氟甲氧基苯基)丙酸乙酯的制备方法 |
CN102212056A (zh) * | 2010-04-09 | 2011-10-12 | 山东轩竹医药科技有限公司 | 新的双环喹诺酮类化合物 |
WO2013121439A2 (en) * | 2012-02-15 | 2013-08-22 | Glenmark Generics Limited | Process for garenoxacin mesylate |
GB201516614D0 (en) * | 2015-09-18 | 2015-11-04 | Redx Pharma Plc | Antibacterial compounds |
CN105837555B (zh) * | 2016-03-31 | 2019-01-25 | 南京华威医药科技集团有限公司 | 加雷沙星及其中间体制备方法 |
CN111620901B (zh) * | 2020-06-08 | 2023-03-21 | 蚌埠医学院第二附属医院 | 一种含硅氧烷基的氟喹诺酮化合物、其制备方法及用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6199835A (ja) * | 1984-10-22 | 1986-05-17 | Shimadzu Corp | 振動試験機の波形補正装置 |
MY105136A (en) * | 1988-04-27 | 1994-08-30 | Daiichi Seiyaku Co | Optically active pyridonecarboxylic acid derivatives. |
RU2049777C1 (ru) * | 1989-08-16 | 1995-12-10 | Пфайзер Инк. | Азабицикло-хинолон-карбоновые кислоты или их фармацевтически приемлемые кислотно-аддитивные соли и промежуточные продукты для их получения |
EG20543A (en) * | 1992-10-30 | 1999-07-31 | Procter & Gamble | Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones |
JPH07300472A (ja) * | 1992-12-28 | 1995-11-14 | Korea Res Inst Chem Technol | 新規キノロンカルボン酸誘導体およびその製造方法 |
JPH06199835A (ja) * | 1993-01-08 | 1994-07-19 | Hokuriku Seiyaku Co Ltd | 8−ジフルオロメトキシキノリン−3−カルボン酸誘導体 |
DE4301246A1 (de) * | 1993-01-19 | 1994-07-21 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäurederivate |
JPH0848629A (ja) * | 1994-08-08 | 1996-02-20 | Dainippon Pharmaceut Co Ltd | ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤 |
DK0775702T3 (da) * | 1994-08-12 | 2003-08-18 | Toyama Chemical Co Ltd | Hidtil ukendte quinolon- eller naphthylidoncarboxylsyrederivater eller salt deraf |
-
1997
- 1997-02-07 CA CA002242242A patent/CA2242242C/en not_active Expired - Lifetime
- 1997-02-07 WO PCT/JP1997/000317 patent/WO1997029102A1/ja active IP Right Grant
- 1997-02-07 KR KR1019980706138A patent/KR100276477B1/ko not_active IP Right Cessation
- 1997-02-07 AU AU16701/97A patent/AU711914B2/en not_active Expired
- 1997-02-07 CN CN97192130A patent/CN1100053C/zh not_active Expired - Lifetime
- 1997-02-07 PT PT97902618T patent/PT882725E/pt unknown
- 1997-02-07 CN CNB011012323A patent/CN100395244C/zh not_active Expired - Lifetime
- 1997-02-07 NZ NZ330775A patent/NZ330775A/xx not_active IP Right Cessation
- 1997-02-07 EP EP97902618A patent/EP0882725B1/en not_active Expired - Lifetime
- 1997-02-07 ES ES97902618T patent/ES2188890T3/es not_active Expired - Lifetime
- 1997-02-07 ZA ZA9701023A patent/ZA971023B/xx unknown
- 1997-02-07 HU HU9901966A patent/HU228567B1/hu unknown
- 1997-02-07 DE DE69717970T patent/DE69717970T2/de not_active Expired - Lifetime
- 1997-02-07 DK DK97902618T patent/DK0882725T3/da active
- 1997-02-07 US US09/125,016 patent/US6025370A/en not_active Expired - Lifetime
- 1997-02-07 AT AT97902618T patent/ATE229950T1/de active
- 1997-02-07 IL IL12494497A patent/IL124944A/xx not_active IP Right Cessation
-
1998
- 1998-08-07 NO NO19983625A patent/NO316666B1/no not_active IP Right Cessation
-
2002
- 2002-01-16 HK HK02100336.1A patent/HK1039118B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69717970T2 (de) | 2003-04-30 |
WO1997029102A1 (fr) | 1997-08-14 |
HK1039118B (zh) | 2009-01-30 |
KR19990082406A (ko) | 1999-11-25 |
DE69717970D1 (de) | 2003-01-30 |
PT882725E (pt) | 2003-04-30 |
ATE229950T1 (de) | 2003-01-15 |
HK1039118A1 (en) | 2002-04-12 |
US6025370A (en) | 2000-02-15 |
DK0882725T3 (da) | 2003-01-13 |
HU228567B1 (en) | 2013-04-29 |
IL124944A (en) | 2003-06-24 |
CA2242242C (en) | 2001-08-07 |
AU1670197A (en) | 1997-08-28 |
HUP9901966A3 (en) | 2002-01-28 |
IL124944A0 (en) | 1999-01-26 |
CN1210533A (zh) | 1999-03-10 |
KR100276477B1 (ko) | 2000-12-15 |
NZ330775A (en) | 1999-08-30 |
EP0882725B1 (en) | 2002-12-18 |
CA2242242A1 (en) | 1997-08-14 |
CN1100053C (zh) | 2003-01-29 |
AU711914B2 (en) | 1999-10-21 |
EP0882725A1 (en) | 1998-12-09 |
NO983625D0 (no) | 1998-08-07 |
NO316666B1 (no) | 2004-03-29 |
NO983625L (no) | 1998-08-07 |
CN100395244C (zh) | 2008-06-18 |
EP0882725A4 (en) | 1999-05-06 |
ES2188890T3 (es) | 2003-07-01 |
ZA971023B (en) | 1997-09-25 |
CN1314355A (zh) | 2001-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9901966A2 (hu) | Kinolonkarbonsavszármazékok vagy sóik | |
DE69331089T2 (de) | Beta-Laktam und Cepham Verbindungen und Ihre Herstellung | |
ES8301998A1 (es) | Un procedimiento para la produccion de nuevas cefalosporinas. | |
AU675695B2 (en) | Cephalosporin derivatives | |
HUP0001269A2 (hu) | 2-Oxo-1-azetidin-szulfonsav-származékok és ezeket tartalmazó kombinált gyógyszerkészítmények | |
IL114875A (en) | Quinolone or naphthylidone-carboxylic acid derivatives or their salts and pharmaceutical compositions containing them | |
ES8704943A1 (es) | Un procedimiento para la fabricacion de derivados de cefalosporina. | |
AU6264194A (en) | Nitrogen-containing fused-heterocycle compounds | |
MY128323A (en) | Thiazole derivatives for inhibition of cytokine production and of cell adhesion | |
ATE347558T1 (de) | Cephem verbindungen und diese enthaltende esbl nachweisreagenzien | |
ES2170804T3 (es) | Derivados de dihidro-2,3-benzodiazepina. | |
HUP9901988A2 (hu) | 2,2'-bi(1H-pirrol)-vegyületet tartalmazó szinergetikus immunszuppresszív készítmény | |
HUP9903751A2 (hu) | 2-Imidazolin-5-on-származékok előállításának köztitermékei | |
ES2039299A1 (es) | Procedimiento de obtencion de esteres de acido 1,1-dioxopenicilanico y sus sales. | |
PT816355E (pt) | Derivados espiro-heterociclicos | |
NO974759L (no) | Cefalosporinpyridiniumderivater | |
AU2231897A (en) | Tricyclic compounds, their production and use | |
TH13812EX (th) | อนุพันธ์ของคาร์บาพีเนมต่อต้านจุลินทรีย์, การ เตรียมสารเหล่านั้นและการใช้สารเหล่านั้นในการ รักษา |